| Elise Fontenot Edwards, MD | |
|
2300 Hospital Dr Ste 120, Bossier City, LA 71111-2193 | |
| (318) 212-7982 | |
| (318) 212-7989 |
| Full Name | Elise Fontenot Edwards |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 2300 Hospital Dr Ste 120, Bossier City, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780048587 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 312926 (Louisiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Elise Fontenot Edwards, MD 2300 Hospital Dr Ste 120, Bossier City, LA 71111-2193 Ph: (318) 212-7982 | Elise Fontenot Edwards, MD 2300 Hospital Dr Ste 120, Bossier City, LA 71111-2193 Ph: (318) 212-7982 |
News Archive
Public awareness campaigns on spotting the signs and symptoms of infectious diseases and how to prevent them, play a key role in helping to stop the spread of such infections, a new study in the journal Epidemiology and Infection reports.
According to a thorough review published by Cochrane Researchers, commonly prescribed antidepressant drugs cannot be recommended for those suffering from autistic spectrum disorders based on current evidence. They say that there may be benefits of antidepressants in adults diagnosed with autism but similar benefits are not seen in children. These children may suffer extremely adverse effects if they consume selective serotonin reuptake inhibitors (SSRIs).
The risk of cardiovascular complications in people with type 2 diabetes is directly related to the frequency and duration of physical exercise, according to results of a large follow-up study reported today on World Diabetes Day. Notably, those with low levels of physical activity had a 70% greater risk of cardiovascular death than those with higher levels.
Genzyme, a Sanofi company, announced today that Brazil's national health surveillance agency, ANVISA, has approved Lemtrada (alemtuzumab) for the treatment of patients with relapsing forms of multiple sclerosis (MS) to slow or reverse the accumulation of physical disability and reduce the frequency of clinical exacerbations.
› Verified 6 days ago
Mandhar R. Manchandia, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2706 Shed Rd, Bossier City, LA 71111 Phone: 318-747-5272 Fax: 318-746-9669 | |
Dr. Zack G Sanders, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2400 Hospital Dr, Ste 120, Bossier City, LA 71111 Phone: 318-742-6710 Fax: 318-747-5393 | |
Randall Glen White Jr., MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2300 Hospital Dr Ste 120, Bossier City, LA 71111 Phone: 318-212-7982 Fax: 318-212-7989 | |
Quynh Tran Dang, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2300 Hospital Dr Ste 340, Bossier City, LA 71111 Phone: 318-212-7883 Fax: 318-212-7885 | |
Dr. Jacqueline J Gray, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2300 Hospital Dr Ste 420, Bossier City, LA 71111 Phone: 318-212-7880 | |
Jennifer Kelley, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 2300 Hospital Dr Ste 300, Bossier City, LA 71111 Phone: 318-212-7793 Fax: 318-212-7795 | |
Dr. Robert Borden Wilson, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2300 Hospital Dr Ste 120, Bossier City, LA 71111 Phone: 318-212-7982 Fax: 318-212-7989 |